Financhill
Back

Credit Acceptance Corp. Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
52

CACC
Credit Acceptance Corp.

Last Price:
$457.70
Seasonality Move:
10.25%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.61
Seasonality Move:
-34.19%
Buy
52
Credit Acceptance Corp. (CACC) is a Buy

Is Credit Acceptance Corp. a Buy, Sell or Hold?

  • The current Credit Acceptance Corp. [CACC] share price is $457.33. The Score for CACC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CACC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $69.69. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CACC Stock Price Chart

What is Credit Acceptance Corp.'s stock price today?

  • The Credit Acceptance Corp. share price today is $457.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CACC is experiencing slight buying pressure.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $69.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight selling pressure.

CACC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.5 Buy
Relative Strength Index (14 RSI): 48.73 Sell
Chaikin Money Flow: 1701 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (440.9 - 472.2) Buy
Bollinger Bands (100): (447.57 - 503.11) Sell

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.55 Buy
Relative Strength Index (14 RSI): 70.17 Buy
Chaikin Money Flow: -284110 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.64 - 66.86) Buy
Bollinger Bands (100): (17.09 - 46.21) Buy

CACC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 459.67 Sell
20-day SMA: 463.16 Sell
50-day SMA: 459.07 Sell
200-day SMA: 486.05 Sell
8-day EMA: 460.83 Sell
20-day EMA: 459.69 Sell
50-day EMA: 462.42 Sell
200-day EMA: 479.49 Sell

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.76 Buy
20-day SMA: 54.7 Buy
50-day SMA: 41.07 Buy
200-day SMA: 26.34 Buy
8-day EMA: 65.27 Buy
20-day EMA: 57.2 Buy
50-day EMA: 45.22 Buy
200-day EMA: 31.64 Buy

Credit Acceptance Corp. Earnings Growth & CACC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.87 per share, and an increase next year of $2.59 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

Credit Acceptance Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):